Patients with diabetes face difficulties in monitoring their risk of developing diabetic retinopathy, lack personalized screening guidance, and often have limited access to educational resources that could enhance their understanding and proactive management of eye health. This results in lower engagement, delayed screenings, and increased risk of vision loss.
A mid-sized health technology company focused on developing digital solutions for chronic disease management and patient engagement, aiming to improve health outcomes through personalized tools.
Successful development of this platform is expected to improve patient self-assessment accuracy, increase engagement through personalized features, and enhance adherence to recommended screenings. These outcomes could lead to early detection of diabetic retinopathy, reducing the risk of vision loss, and ultimately improving health outcomes for diabetic patients while supporting healthcare providers with proactive monitoring tools.